EurA1c: a review of 9 years performance of up to 5120 laboratories in 29 country and 26 manufacturer groups according to current and proposed criteria of the IFCC Model for Quality Targets in relation to the use of HbA1c for monitoring and diagnosis of diabetes.
Saved in:
| Title: | EurA1c: a review of 9 years performance of up to 5120 laboratories in 29 country and 26 manufacturer groups according to current and proposed criteria of the IFCC Model for Quality Targets in relation to the use of HbA |
|---|---|
| Corporate Authors: | EurA1c Trial Group |
| Source: | Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2026 May 19; Vol. 64 (8), pp. 1886-1900. Date of Electronic Publication: 2026 May 19 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Walter De Gruyter Country of Publication: Germany NLM ID: 9806306 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1437-4331 (Electronic) Linking ISSN: 14346621 NLM ISO Abbreviation: Clin Chem Lab Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1437-4331 |
|---|---|
| DOI: | 10.1515/cclm-2026-0276 |
